MondegarAI
Alphabet Inc. (GOOG, GOOGL)

Q3 2025 · 13F-HR

Alphabet Inc. (GOOG, GOOGL)holdings as filed

Filed 2025-11-07 · accession 0001652044-25-000096

$2.41B
Reported value
37
Positions
2025-09-30
Period end
View analyzed profile →PRO

The Brief · Alphabet Inc. (GOOG, GOOGL) · Q3 2025

AI · grounded in 13F

Alphabet Inc. (GOOG, GOOGL) established a new position in AST SPACEMOBILE INC ASTS valued at $438.9M. The fund also initiated new stakes in PLANET LABS PBC PL for $414.6M and ARM HOLDINGS PLC ARM for $277.4M. Other new additions include METSERA INC for $198M and REVOLUTION MEDICINES INC RVMD for $193M.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
00217D100ASTSAST SPACEMOBILE INC$438.9M18.2%8,943,486CommonSHARED
72703X106PLPLANET LABS PBC$414.6M17.2%31,942,641CommonSHARED
042068205ARMARM HOLDINGS PLC$277.4M11.5%1,960,784CommonSHARED
59267L107METSERA INC$198.0M8.22%3,783,528CommonSHARED
76155X100RVMDREVOLUTION MEDICINES INC$193.0M8.01%4,133,277CommonSHARED
358054104FRSHFRESHWORKS INC$190.8M7.92%16,206,643CommonSHARED
88023B103TEMTEMPUS AI INC$125.2M5.20%1,551,102CommonSHARED
37637K108GTLBGITLAB INC$122.8M5.10%2,724,712CommonSHARED
90364P105PATHUIPATH INC$94.1M3.91%7,034,337CommonSHARED
74168J101PRMEPRIME MEDICINE INC$91.8M3.81%16,562,498CommonSHARED
252131107DXCMDEXCOM INC$69.8M2.90%1,036,937CommonSHARED
578784100MAZEMAZE THERAPEUTICS INC$62.6M2.60%2,412,471CommonSHARED
107924102BBOTBRIDGEBIO ONCOLOGY THERAPEUT$32.7M1.36%2,823,126CommonSHARED
316841105FIGFIGMA INC$11.2M0.46%215,582CommonSHARED
61225M102GLUEMONTE ROSA THERAPEUTICS INC$10.8M0.45%1,464,015CommonSHARED
799566104SANASANA BIOTECHNOLOGY INC$10.0M0.41%2,812,500CommonSHARED
687793109OSCROSCAR HEALTH INC$9.1M0.38%481,988CommonSHARED
252828108DNTHDIANTHUS THERAPEUTICS INC$8.2M0.34%208,697CommonSHARED
75943R102RLAYRELAY THERAPEUTICS INC$8.2M0.34%1,568,753CommonSHARED
07373V105BEAMBEAM THERAPEUTICS INC$7.8M0.32%321,604CommonSHARED
92337R101VERAVERA THERAPEUTICS INC$7.0M0.29%241,264CommonSHARED
55083R203LYELLYELL IMMUNOPHARMA INC$4.8M0.20%293,256CommonSHARED
344174107FHTXFOGHORN THERAPEUTICS INC$2.4M0.10%500,901CommonSHARED
81663L200WGSGENEDX HOLDINGS CORP$2.4M0.10%22,711CommonSHARED
877619106TSHATAYSHA GENE THERAPIES INC$2.1M0.09%640,882CommonSHARED
89854M101TCRXTSCAN THERAPEUTICS INC$2.0M0.08%1,077,080CommonSHARED
91864C107BRNSBARINTHUS BIOTHERAPEUTICS PL$1.9M0.08%1,513,644CommonSHARED
84833T103SPROSPERO THERAPEUTICS INC$1.7M0.07%889,979CommonSHARED
87990A106TNYATENAYA THERAPEUTICS INC$1.5M0.06%915,705CommonSHARED
44916K106HYPRHYPERFINE INC$1.3M0.05%898,720CommonSHARED
30063P105EXKEXACT SCIENCES CORP$1.3M0.05%23,205CommonSHARED
05280R100AUTLAUTOLUS THERAPEUTICS PLC$1.1M0.05%698,262CommonSHARED
35168W103GUTSFRACTYL HEALTH INC$1.1M0.04%662,584CommonSHARED
014442107ALECALECTOR INC$520,5630.02%175,866CommonSHARED
22053A107QNCXQUINCE THERAPEUTICS INC$308,2690.01%189,122CommonSHARED
359616109FULCFULCRUM THERAPEUTICS INC$131,2100.01%14,262CommonSHARED
759916109RGENREPLIGEN CORP$51,1960.00%383CommonSHARED

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.